Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):208–215. doi: 10.1097/QAI.0b013e3182645679

Table 2.

Baseline characteristics of the study cohort.

Characteristic Control condition
(N=72*)
Intervention condition
(N=73*)
P

Age 47.9±6.6 49.2±7.4 0.24
Gender
     Male 35 (48.6%) 36 (49.3%)
     Female 37 (51.4%) 36 (49.3%) 0.60
     Transgender 0 (0.0%) 1 (1.4%)
Ethnicity
     Latino 18 (25.7%) 13 (19.7%) 0.40
     Non-Latino 52 (74.3%) 53 (80.3%)
Race
     Black/African American 54 (85.7%) 55 (85.9%)
     White 7 (11.1%) 7 (10.9%) 0.99
     American Indian or Alaskan native 2 (3.2%) 2 (3.1%)
Marital status
     Married/living with partner 17 (25.8%) 13 (20.6%) 0.49
     Single 49 (74.2%) 50 (79.4%)
Housing status
     Stable 63 (88.7%) 66 (90.4%)
     Transitional 7 (9.9%) 6 (8.2%) 0.94
     Homeless 1 (1.4%) 1 (1.4%)
Employment status
     Unemployed/disabled 56 (88.9%) 61 (87.1%)
     Part-time employment 5 (7.9%) 9 (12.9%) 0.22
     Full-time employment 2 (3.2%) 0 (0.0%)
HIV risk behavior
     Heterosexual contact 46 (63.9%) 38 (52.8%)
     Same sex contact 8 (11.1%) 13 (18.1%)
     Injection drug use 5 (6.9%) 8 (11.1%) 0.43
     Transfusion 3 (4.2%) 1 (1.4%)
     Other/unknown 10 (13.9%) 12 (16.7%)
Most recent CD4+ count (cells/ul) 483.2±248.9 504.4±326.1 0.66
Daily cigarette consumption 11.1±7.3 12.8±10.1 0.25
Nicotine dependence score** 5.2±2.0 4.8±2.1 0.19
Motivation to quit*** 7.3±0.9 7.4±0.9 0.44
*

Response totals do not equal the cohort size for all items because of incomplete reporting.

**

As measured using the Modified Fagerstrom Tolerance Questionnaire23

***

As measured using the Abrams and Biener Readiness to Quit Ladder21

HHS Vulnerability Disclosure